Tests et dépistage auditifs chez les jeunes enfants
Revu par Dr Krishna Vakharia, MRCGPDernière mise à jour par Dr Colin Tidy, MRCGPDernière mise à jour 21 juin 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Professionnels de la santé
Les articles de référence professionnelle sont conçus pour être utilisés par les professionnels de la santé. Ils sont rédigés par des médecins britanniques et basés sur des preuves de recherche, des directives britanniques et européennes. Vous pouvez trouver le Test auditif néonatal article plus utile, ou l'un de nos autres articles de santé.
Introduction
About 1,300 children born in the UK each year have permanent hearing loss in one or both ears of moderate or worse severity.1
About 50-60% of people with hearing loss have a genetic aetiology; the remaining 40-50% of cases are attributed to environmental factors such as ototoxic drugs, prematurity, or trauma.2
The Newborn Hearing Screening Programme was introduced in the UK in 2006, replacing the previous infant screening programme (the 'distraction test' at 8 months). Most congenitally deaf children are now identified and managed appropriately before 6 months of age. Identification of permanent hearing impairment at the earliest possible age is crucial to maximise the development of speech and language.
Rationale for screening1
Universal newborn hearing screening identifies the majority of the 1 in 1,000 children born with a hearing impairment.
Hearing loss is not confined to those with risk factors - approximately 40% of all children ultimately identified with sensorineural hearing loss do not have an established risk factor; therefore, universal screening is recommended.
Hearing screening allows hearing loss to be identified at a younger age. There is good evidence that this is beneficial because early detection and management improve outcomes in terms of speech, language and education.3 4
The critical age for commencing intervention may be as early as 6 months.
Parents may quickly recognise a baby as having severe or profound hearing loss; however, moderate hearing loss or high-frequency hearing loss may go unnoticed for several years unless formally tested.
Screening tests for hearing loss1
The coverage and newborn hearing screening uptake across England is around 98%. Although the vast majority of babies pass the test, around 2% of babies are referred to audiology services for further assessment.
Neonatal hearing screening tests
Automated otoacoustic emissions (AOAE) test
The AOAE test measures the integrity of the inner ear.
It works on the following principle:
In the healthy cochlea, vibration of the hair cells in response to noise generates acoustic energy, known as otoacoustic emissions. A probe is placed in the ear canal and generates wide-band clicks. Acoustic energy produced in response to the clicks is detected by a microphone within the probe.
AOAE screeners display the results of the test as either pass ou refer, requiring no test interpretation by staff.
The test takes a few minutes.
Automated auditory brainstem responses (AABR) test
The AABR test measures not only the integrity of the inner ear but also the auditory pathway.
It can therefore detect the rare condition of auditory neuropathy in children who are deaf but have normal otoacoustic emissions (because the cochlea is normal).
The stimulus (either clicks or tones) is presented using earphones or an ear canal probe, and the electrophysiological response from the brainstem is detected by scalp electrodes. Automated devices allow screening to be performed by non-specialists.
This test takes 15 minutes.
Test limitations
Both tests require a quiet baby and a quiet environment.
Debris in the canal or middle ear fluid can affect the tests (including amniotic fluid in the ear canal following birth).
Only the AABR test will detect auditory neuropathy (where the cochlea is normal).
Neither test will detect central hearing impairment (where hearing loss is secondary to dysfunction of the pathways from brainstem to auditory cortex).
Current screening protocols in the United Kingdom1
Newborns
Well baby protocol:
For babies who had no requirement for special care (or <48 hours in special care).
Uses the AOAE test. Babies not passing this test are given the AABR test.
Neonatal intensive care/special care baby unit protocol:
Uses both AOAE and AABR tests. The latter can detect auditory neuropathy, which is more common in special care babies.
Then:
If these tests are not 'passed', babies are referred for audiological assessment within four weeks of screening or when the baby is 44 weeks of gestational age.
If there are risk factors requiring surveillance, refer for continued audiological assessment at 7-9 months of age.
School entry hearing test
Currently, this is performed in most areas of the UK.
Later-onset hearing impairment can occur at any time and there is no optimum time for further screening.
The test used is the 'pure tone sweep test' which is pure tone audiometry.
Following the introduction of newborn screening, most cases of hearing impairment will be identified before school entry; however, there will be some cases that were missed or have developed after the test.
This non-standardised school entry screening (SES) programme which is in place in many parts of the UK, is of questionable value.5
Further hearing tests in children
Various tests can be performed by the audiological service, depending on the age of the child and the level of co-operation. For example, in the 'toy test' the child points to toys named in a low voice by the tester. Pure tone audiometry is used with older children who can co-operate.
Visual reinforcement audiometry (VRA) is now used in preference to distraction testing. The test is a behavioural test which can be carried out with young children between the developmental ages of 7 months and 3 years.
Awareness and referral during childhood6
Voir aussi l'article sur Deafness in Children.
Even if the hearing screening tests have been 'passed', parents and carers should continue to be vigilant for signs of hearing loss. This is because:
Hearing loss may develop later.
Some children may have missed out on screening programmes - eg, new immigrants.
Some hearing loss may be missed on screening.
High-frequency loss may not be obvious to family and carers but will nevertheless impair understanding of speech.
Symptoms of hearing loss
The child may be:
Inattentive, not reacting when called.
Talking too loudly, listening to TV at high volume.
Mispronouncing words.
Unsettled at school.
Tired, grumpy or overactive.
Demonstrating difficult or withdrawn behaviour.
Who should be referred for audiology assessment?
Referral criteria will vary slightly with local service provision but the following is a guide:
Those children who did not pass the screening test.
Those children who missed their screening test.
Babies with the following risk factors, who should be considered for referral for targeted follow-up, even if they pass the screening tests:
High risk of middle ear problems: syndromes associated with hearing loss (eg, syndrome de Down, Syndrome de Turner), cleft palate, other craniofacial abnormalities (eg, atresia/microtia of the ear canal; chromosomal or syndromic conditions, branchial arch and cervical spine anomalies).
Congenital infection due to la toxoplasmose, rubella or cytomegalovirus.
Had special care for >48 hours, and no clear response to AOAE in both ears despite clear response on AABR.
Babies with the following risk factors should be referred to Audiology for assessment:
Any parental or professional concern.
Confirmed or strongly suspected bacterial meningitis, or meningococcal septicaemia.
Temporal bone fracture.
Severe unconjugated hyperbilirubinaemia.
Children with delayed speech and language may also require referral.
After treatment with ototoxic drugs (eg, aminoglycosides), they should be referred only at the discretion of a paediatrician.
Any parents who express concerns about hearing despite the screen should toujours be referred to Audiology.
Mises à jour exclusives pour les professionnels de la santé
Restez informé des dernières mises à jour cliniques, des perspectives professionnelles et des conseils fondés sur des preuves. La newsletter Patient Pro sélectionne des contenus essentiels pour les professionnels de santé—livrés directement dans votre boîte de réception.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.
Lectures complémentaires et références
- Société nationale des enfants sourds
- Butcher E, Dezateux C, Knowles RL; Risk factors for permanent childhood hearing impairment. Arch Dis Child. 2020 Feb;105(2):187-189. doi: 10.1136/archdischild-2018-315866. Epub 2018 Nov 28.
- Child screening programme Hearing (child); UK National Screening Committee, 2019
- Angeli S, Lin X, Liu XZ; Genetics of hearing and deafness. Anat Rec (Hoboken). 2012 Nov;295(11):1812-29. doi: 10.1002/ar.22579. Epub 2012 Oct 8.
- Pimperton H, Blythe H, Kreppner J, et al; The impact of universal newborn hearing screening on long-term literacy outcomes: a prospective cohort study. Arch Dis Child. 2016 Jan;101(1):9-15. doi: 10.1136/archdischild-2014-307516. Epub 2014 Nov 25.
- Ching TY; Is Early Intervention Effective in Improving Spoken Language Outcomes of Children With Congenital Hearing Loss? Am J Audiol. 2015 Sep;24(3):345-8.
- Fortnum H, Ukoumunne OC, Hyde C, et al; A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes. Health Technol Assess. 2016 May;20(36):1-178. doi: 10.3310/hta20360.
- Société nationale des enfants sourds
À propos du critiqueVoir la biographie complète

Dr Krishna Vakharia, MRCGP
Médecin-chef pour la santé, Optum UK
MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)
Le Dr Krishna Vakharia est un médecin généraliste du NHS. Elle est également examinatrice régulière pour le diplôme de troisième cycle en dermatologie pratique à l'Université de Cardiff, ainsi que médecin-chef pour la santé chez Optum UK.
Historique de l'article
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
Prochaine révision prévue : 19 juin 2028
21 juin 2023 | Dernière version
Plus en pédiatrie
- Infections congénitales, périnatales et néonatales
- Déshydratation chez les enfants
- Dystrophie musculaire de Duchenne
- Épilepsie chez les enfants et les jeunes
- Maladie fabriquée ou induite par les soignants
- Première crise d'épilepsie
- Gastro-entérite chez les enfants
- Haemophilus influenzae
- Douleur à la hanche chez les enfants
- Sténose hypertrophique du pylore infantile
- Dermatose plantaire juvénile
- la maladie de Kawasaki
- Gestion de l'asthme chez l'enfant
- Molluscum contagiosum
- Défauts du tube neural
- PANDAS
- Phimosis et paraphimosis
- Douleurs abdominales récurrentes chez les enfants
- Syndrome de West
- Coqueluche


